Cargando…
Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Immune checkpoint inhibitors (ICIs) have become important treatment strategies, yet responses vary among patients and predictive biomarkers are urgently needed. Mutations in KMT2C and KMT2D lead to increased levels of genomic instability. Therefore, we aimed to examine whether KMT2C/D mutations migh...
Autores principales: | Liu, Ruiqi, Niu, Yanling, Liu, Chao, Zhang, Xin, Zhang, Jinku, Shi, Min, Zou, Wenbo, Gu, Binbin, Zhu, Honglin, Wang, Danhua, Yuan, Hongling, Li, Wei, Zhao, Dandan, Zheng, Qiaosong, Liu, Rong, Chen, Weiping, Ma, Tonghui, Zhang, Yanqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067420/ https://www.ncbi.nlm.nih.gov/pubmed/36601880 http://dx.doi.org/10.1111/cas.15716 |
Ejemplares similares
-
Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022) -
Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018) -
Genomic alterations in KMT2 family predict outcome of immune checkpoint therapy in multiple cancers
por: Zhang, Peng, et al.
Publicado: (2021) -
Immune checkpoint blockades in gynecological cancers: A review of clinical trials
por: Peng, Hongling, et al.
Publicado: (2022) -
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing
por: Shi, Minke, et al.
Publicado: (2021)